1. Home
  2. ELMT vs EDIT Comparison

ELMT vs EDIT Comparison

Compare ELMT & EDIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo The Elmet Group Co. Common Stock

ELMT

The Elmet Group Co. Common Stock

N/A

Current Price

$19.69

Market Cap

474.9M

Sector

Industrials

ML Signal

N/A

Logo Editas Medicine Inc.

EDIT

Editas Medicine Inc.

N/A

Current Price

$1.77

Market Cap

422.3M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ELMT
EDIT
Founded
1929
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Metal Fabrications
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
474.9M
422.3M
IPO Year
2026
2016

Fundamental Metrics

Financial Performance
Metric
ELMT
EDIT
Price
$19.69
$1.77
Analyst Decision
Strong Buy
Buy
Analyst Count
4
13
Target Price
★ $29.00
$6.10
AVG Volume (30 Days)
472.3K
★ 2.1M
Earning Date
11-09-2026
11-09-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 37.50
EPS
★ 0.10
N/A
Revenue
N/A
★ $31,937,000.00
Revenue This Year
$34.89
N/A
Revenue Next Year
$29.22
N/A
P/E Ratio
$194.45
★ N/A
Revenue Growth
N/A
★ 132.64
52 Week Low
$12.49
$1.66
52 Week High
$25.46
$3.94

Technical Indicators

Market Signals
Indicator
ELMT
EDIT
Relative Strength Index (RSI) 46.04 30.69
Support Level $17.53 N/A
Resistance Level $21.38 $3.00
Average True Range (ATR) 2.19 0.21
MACD -0.20 -0.09
Stochastic Oscillator 31.09 1.18

Price Performance

Historical Comparison
ELMT
EDIT

About ELMT The Elmet Group Co. Common Stock

The Elmet Group Co provides precision-engineered components and high-energy systems for the Aerospace, Defense and Government, Industrial, Medical, Semiconductor and Electronics, and Energy industries. The company is organized into two business divisions, Critical Materials Components and Engineered Microwave Products, offering a platform with expertise across interconnected markets. The company operates an integrated engineering-to-production system, covering custom design, development, and processing across Critical Materials and High-Power Microwave. Its Engineered Microwave capabilities helps to deliver tailored microwave energy solutions, while its Critical Materials expertise allows to design reliable solutions for some of the demanding environments in the world.

About EDIT Editas Medicine Inc.

Editas Medicine Inc is a clinical-stage genome editing company dedicated to developing potentially transformative genomic medicines to treat a broad range of serious diseases. The company focuses on developing a proprietary gene editing platform based on CRISPR technology and continues to expand its capabilities. CRISPR uses a protein-RNA complex composed of an enzyme, including either Cas9 (CRISPR-associated protein 9) or Cas12a (CRISPR from Prevotella and Francisella 1, also known as Cpf1). The company has a single operating segment, which is the business of developing and commercializing gene editing technology.

Share on Social Networks: